247 related articles for article (PubMed ID: 28572169)
1. Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth
Muralidharan R; Babu A; Amreddy N; Srivastava A; Chen A; Zhao YD; Kompella UB; Munshi A; Ramesh R
Mol Cancer Ther; 2017 Aug; 16(8):1470-1486. PubMed ID: 28572169
[TBL] [Abstract][Full Text] [Related]
2. Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration.
Muralidharan R; Babu A; Amreddy N; Basalingappa K; Mehta M; Chen A; Zhao YD; Kompella UB; Munshi A; Ramesh R
J Nanobiotechnology; 2016 Jun; 14(1):47. PubMed ID: 27328938
[TBL] [Abstract][Full Text] [Related]
3. HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells.
Muralidharan R; Mehta M; Ahmed R; Roy S; Xu L; Aubé J; Chen A; Zhao YD; Herman T; Ramesh R; Munshi A
Sci Rep; 2017 Aug; 7(1):9694. PubMed ID: 28855578
[TBL] [Abstract][Full Text] [Related]
4. HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration and invasion in lung cancer.
Muralidharan R; Panneerselvam J; Chen A; Zhao YD; Munshi A; Ramesh R
Cancer Gene Ther; 2015 Dec; 22(12):581-90. PubMed ID: 26494555
[TBL] [Abstract][Full Text] [Related]
5. Targeting the interaction between RNA-binding protein HuR and FOXQ1 suppresses breast cancer invasion and metastasis.
Wu X; Gardashova G; Lan L; Han S; Zhong C; Marquez RT; Wei L; Wood S; Roy S; Gowthaman R; Karanicolas J; Gao FP; Dixon DA; Welch DR; Li L; Ji M; Aubé J; Xu L
Commun Biol; 2020 Apr; 3(1):193. PubMed ID: 32332873
[TBL] [Abstract][Full Text] [Related]
6. Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells.
Jimbo M; Blanco FF; Huang YH; Telonis AG; Screnci BA; Cosma GL; Alexeev V; Gonye GE; Yeo CJ; Sawicki JA; Winter JM; Brody JR
Oncotarget; 2015 Sep; 6(29):27312-31. PubMed ID: 26314962
[TBL] [Abstract][Full Text] [Related]
7. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
[TBL] [Abstract][Full Text] [Related]
8. An RNA-Binding Protein, Hu-antigen R, in Pancreatic Cancer Epithelial to Mesenchymal Transition, Metastasis, and Cancer Stem Cells.
Dong R; Chen P; Polireddy K; Wu X; Wang T; Ramesh R; Dixon DA; Xu L; Aubé J; Chen Q
Mol Cancer Ther; 2020 Nov; 19(11):2267-2277. PubMed ID: 32879054
[TBL] [Abstract][Full Text] [Related]
9. A Feed-Forward Regulatory Loop between HuR and the Long Noncoding RNA HOTAIR Promotes Head and Neck Squamous Cell Carcinoma Progression and Metastasis.
Xu CZ; Jiang C; Wu Q; Liu L; Yan X; Shi R
Cell Physiol Biochem; 2016; 40(5):1039-1051. PubMed ID: 27941336
[TBL] [Abstract][Full Text] [Related]
10. Chemo-biologic combinatorial drug delivery using folate receptor-targeted dendrimer nanoparticles for lung cancer treatment.
Amreddy N; Babu A; Panneerselvam J; Srivastava A; Muralidharan R; Chen A; Zhao YD; Munshi A; Ramesh R
Nanomedicine; 2018 Feb; 14(2):373-384. PubMed ID: 29155362
[TBL] [Abstract][Full Text] [Related]
11. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
[TBL] [Abstract][Full Text] [Related]
12. Assessment of drug delivery and anticancer potentials of nanoparticles-loaded siRNA targeting STAT3 in lung cancer, in vitro and in vivo.
Das J; Das S; Paul A; Samadder A; Bhattacharyya SS; Khuda-Bukhsh AR
Toxicol Lett; 2014 Mar; 225(3):454-66. PubMed ID: 24440344
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral delivery and therapeutic efficacy of nanoparticle-encapsulated anti-tumor siRNA following intrapulmonary administration for potential treatment of lung cancer.
Kanehira Y; Togami K; Ishizawa K; Sato S; Tada H; Chono S
Pharm Dev Technol; 2019 Nov; 24(9):1095-1103. PubMed ID: 31204552
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis in non-small cell lung cancer by downregulation of MDM2 using pH-responsive PMPC-b-PDPA/siRNA complex nanoparticles.
Yu H; Zou Y; Jiang L; Yin Q; He X; Chen L; Zhang Z; Gu W; Li Y
Biomaterials; 2013 Apr; 34(11):2738-47. PubMed ID: 23352573
[TBL] [Abstract][Full Text] [Related]
15. Delivery of Therapeutics Targeting the mRNA-Binding Protein HuR Using 3DNA Nanocarriers Suppresses Ovarian Tumor Growth.
Huang YH; Peng W; Furuuchi N; Gerhart J; Rhodes K; Mukherjee N; Jimbo M; Gonye GE; Brody JR; Getts RC; Sawicki JA
Cancer Res; 2016 Mar; 76(6):1549-59. PubMed ID: 26921342
[TBL] [Abstract][Full Text] [Related]
16. Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles.
Nascimento AV; Singh A; Bousbaa H; Ferreira D; Sarmento B; Amiji MM
Acta Biomater; 2017 Jan; 47():71-80. PubMed ID: 27697601
[TBL] [Abstract][Full Text] [Related]
17. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
18. Posttranscriptional Regulation of
Chand SN; Zarei M; Schiewer MJ; Kamath AR; Romeo C; Lal S; Cozzitorto JA; Nevler A; Scolaro L; Londin E; Jiang W; Meisner-Kober N; Pishvaian MJ; Knudsen KE; Yeo CJ; Pascal JM; Winter JM; Brody JR
Cancer Res; 2017 Sep; 77(18):5011-5025. PubMed ID: 28687616
[TBL] [Abstract][Full Text] [Related]
19. Drug delivery approaches for HuR-targeted therapy for lung cancer.
Raguraman R; Shanmugarama S; Mehta M; Elle Peterson J; Zhao YD; Munshi A; Ramesh R
Adv Drug Deliv Rev; 2022 Jan; 180():114068. PubMed ID: 34822926
[TBL] [Abstract][Full Text] [Related]
20. Human antigen R affects the migration and invasion of human lung cancer A549 cells via regulating E-cadherin suppressor Snail.
Shan S; Bao Q; Ma G; Yao Y; Xiong J; You J
Cell Mol Biol (Noisy-le-grand); 2022 Jun; 68(6):9-16. PubMed ID: 36227684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
